Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma

Abstract Background High-grade lymphoma in dogs is a chemotherapy-responsive neoplasia with remission rates exceeding 80% under combination chemotherapy protocols. Usually these protocols are intensive and 24 + weeks. The objective of the present study was to investigate if a shorter protocol combin...

Full description

Bibliographic Details
Main Authors: Stefanie Limmer, Verena Nerschbach, Nina Eberle, Erik Teske, Daniela Simon Betz
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Acta Veterinaria Scandinavica
Subjects:
Online Access:https://doi.org/10.1186/s13028-022-00660-z